Does OBINUTUZUMAB Cause Aspergillus infection? 356 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 356 reports of Aspergillus infection have been filed in association with OBINUTUZUMAB (Gazyva). This represents 2.5% of all adverse event reports for OBINUTUZUMAB.
356
Reports of Aspergillus infection with OBINUTUZUMAB
2.5%
of all OBINUTUZUMAB reports
17
Deaths
24
Hospitalizations
How Dangerous Is Aspergillus infection From OBINUTUZUMAB?
Of the 356 reports, 17 (4.8%) resulted in death, 24 (6.7%) required hospitalization, and 3 (0.8%) were considered life-threatening.
Is Aspergillus infection Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OBINUTUZUMAB. However, 356 reports have been filed with the FAERS database.
What Other Side Effects Does OBINUTUZUMAB Cause?
Off label use (1,584)
Neutropenia (1,276)
Febrile neutropenia (955)
Covid-19 (942)
Pyrexia (920)
Thrombocytopenia (889)
Disease progression (831)
Infusion related reaction (789)
Pneumonia (662)
Anaemia (640)
What Other Drugs Cause Aspergillus infection?
PREDNISONE (1,231)
TACROLIMUS (1,099)
RITUXIMAB (952)
MYCOPHENOLATE MOFETIL (888)
METHOTREXATE (828)
METHYLPREDNISOLONE (788)
DEXAMETHASONE (785)
CYCLOPHOSPHAMIDE (733)
ETOPOSIDE (676)
PREDNISOLONE (667)
Which OBINUTUZUMAB Alternatives Have Lower Aspergillus infection Risk?
OBINUTUZUMAB vs OCELLA
OBINUTUZUMAB vs OCRELIZUMAB
OBINUTUZUMAB vs OCRIPLASMIN
OBINUTUZUMAB vs OCTINOXATE\OCTISALATE\ZINC
OBINUTUZUMAB vs OCTINOXATE\OCTOCRYLENE